These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17554793)

  • 1. Improvement in the outcome of children with germ cell tumors.
    Lopes LF; Sonaglio V; Ribeiro KC; Schneider DT; de Camargo B
    Pediatr Blood Cancer; 2008 Feb; 50(2):250-3. PubMed ID: 17554793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91.
    Lopes LF; Macedo CR; Pontes EM; Dos Santos Aguiar S; Mastellaro MJ; Melaragno R; Vianna SM; Lopes PA; Mendonça N; de Assis Almeida MT; Sonaglio V; Ribeiro KB; Santana VM; Schneider DT; de Camargo B
    J Clin Oncol; 2009 Mar; 27(8):1297-303. PubMed ID: 19164215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular germ cell tumors in childhood: treatment results of 52 patients.
    Güler E; Tezer Kutluk M; Büyükpamukçu N; Caglar M; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2004; 21(1):49-56. PubMed ID: 14660306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
    Jahnke K; Kraemer DF; Knight KR; Fortin D; Bell S; Doolittle ND; Muldoon LL; Neuwelt EA
    Cancer; 2008 Feb; 112(3):581-8. PubMed ID: 18072268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of ovarian germ cell tumors.
    Williams SD
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
    Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91".
    Lo Curto M; Lumia F; Alaggio R; Cecchetto G; Almasio P; Indolfi P; Siracusa F; Bagnulo S; De Bernardi B; De Laurentis T; Di Cataldo A; Tamaro P
    Med Pediatr Oncol; 2003 Nov; 41(5):417-25. PubMed ID: 14515380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of multimodality therapy of testicular germ cell tumor].
    Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
    Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
    Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.